Skip to content

Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma

Suction Drain Volume Following Axillary Lymph Node Dissection for Malignant Melanoma - When to Remove Drains? A Retrospective Cohort Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04648163
Enrollment
118
Registered
2020-12-01
Start date
2017-12-01
Completion date
2018-09-01
Last updated
2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Melanoma

Brief summary

Postoperative complications like seroma formation and wound site infection readily occur following completion axillary lymph node dissection (ALND) for malignant melanoma. We analyzed the impact of time-to-drain removal and drainage volume on seroma formation after ALND.

Interventions

None listed

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* histologically confirmed malignant melanoma * underwent axillary lymph node dissection (level I-III) * daily drainage volume records over a two-week period available

Exclusion criteria

* daily drainage volume records over a two-week period not available

Design outcomes

Primary

MeasureTime frameDescription
daily drainage volume during hospitalizationthrough study completion, an average of 1 yearThe daily drainage amount durin hospital stay
total drainage volume during hospitalizationthrough study completion, an average of 1 yearThe total drainage amount during hospital stay
time-to-drain removalthrough study completion, an average of 1 yearThe timepoint when the drain was removed
evacuation of seroma after drain removalthrough study completion, an average of 1 yearIf evacuation of seroma after drain removal was needed

Secondary

MeasureTime frameDescription
demographic data - Diabetes mellitusthrough study completion, an average of 1 yeardiabetes mellitus
demographic data - allergiesthrough study completion, an average of 1 yearallergies
intraoperative parametersthrough study completion, an average of 1 yearsurgical procedure time
demographic data - agethrough study completion, an average of 1 yearage
Amount of histologically analyzed lymph nodesthrough study completion, an average of 1 yearThe amount lymph nodes found at histological analysis
Surgical complicationsthrough study completion, an average of 1 yeargraded by the Clavien-Dindo-classification ( 1:normal postoperative cause without need of pharmacological treatment ; 2: pharmacological treatment ; 3: surgical, endoscooic or radiological treatment; 4: live-threating complications; 5: Death
intraoperative parameters - sitethrough study completion, an average of 1 yearsite
demographic data - sexthrough study completion, an average of 1 yearsex
demographic data - BMIthrough study completion, an average of 1 yearbody mass index (BMI)
demographic data - smokingthrough study completion, an average of 1 yearsmoking

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026